Welcome to Ypsomed

Spacer

Ypsomed is a worldwide leading independent developer and manufacturer of injection systems for custom-made self-administration and supplier of pen needles for the treatment of diabetes, growth disorders or infertility, as well as for further therapeutic areas. Ypsomed has well-established partnerships with numerous leading pharmaceutical and biotech companies such as Sanofi-Aventis, Eli Lilly, Pfizer, Roche, Genentech, Merck Serono, Amylin, NPS and others.

Ypsomed is headquartered in Burgdorf, Switzerland, and employs over 1200 employees at several production sites in Switzerland and throughout a European sales and distribution network.



© Copyright Ypsomed 2003- All rights reserved

News: 24th February 2010

Adaptation of Pen Production Capacity – Expanding and Optimizing the European Diabetes Sales... >>>more

News: 16th February 2010

Bionime Corporation and Ypsomed AG announce new US retail initiative >>>more

News: 5th January 2010

Ypsomed exclusively launches the mylife™ OmniPod® insulin patch pump outside of USA >>>more

News: 22nd December 2009

Ypsomed’s Ypsopen® will be launched in Russia and pen needles in Ukraine >>>more

News: 3rd November 2009

Semiannual report 2009/10 >>>more